Agency Information Collection Activities: Proposed Collection; Comment Request, 11359-11361 [2017-03463]

Download as PDF Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices as a group acting in concert, to acquire voting shares of Citizens Bancshares, Inc. Walnut, Illinois, and thereby indirectly acquire shares of Citizens First State Bank of Walnut, Walnut, Illinois. B. Federal Reserve Bank of Minneapolis (Jacquelyn K. Brunmeier, Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. Patrick Artz, Richard Kornkven, and Monte Mikkelsen, all of Bottineau, North Dakota; to each acquire voting shares of State Bank of Bottineau Holding Company, Bottineau, North Dakota, and thereby indirectly acquire shares of State Bank of Bottineau, Bottineau, North Dakota. Board of Governors of the Federal Reserve System, February 15, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–03376 Filed 2–21–17; 8:45 am] BILLING CODE 6210–01–P FEDERAL RESERVE SYSTEM sradovich on DSK3GMQ082PROD with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of VerDate Sep<11>2014 16:05 Feb 21, 2017 Jkt 241001 Governors not later than March 14, 2017. A. Federal Reserve Bank of Minneapolis (Jacquelyn K. Brunmeier, Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. First Interstate BancSystem, Inc., Billings, Montana; to acquire 100 percent of Cascade Bancorp, Inc., Bend, Oregon, and thereby acquire Bank of the Cascades, Bend, Oregon. Board of Governors of the Federal Reserve System, February 16, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–03450 Filed 2–21–17; 8:45 am] 11359 1. Pinnacle Financial Partners, Inc., Nashville, Tennessee; to merge with BNC Bancorp, High Point, North Carolina, and thereby acquire Bank of North Carolina, Thomasville, North Carolina. Board of Governors of the Federal Reserve System, February 15, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–03375 Filed 2–21–17; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–P Agency for Healthcare Research and Quality FEDERAL RESERVE SYSTEM Agency Information Collection Activities: Proposed Collection; Comment Request Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than March 13, 2017. A. Federal Reserve Bank of Atlanta (Chapelle Davis, Assistant Vice President) 1000 Peachtree Street NE., Atlanta, Georgia 30309. Comments can also be sent electronically to Applications.Comments@atl.frb.org: PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) to review again proposed information collection project: Pharmacy Survey on Patient Safety Culture Comparative Database.’’ This proposed information collection was previously published in the Federal Register on November 18, 2016 and allowed 60 days for public comment. AHRQ did not receive any substantive comments. The purpose of this notice is to allow an additional 30 days for public comment. DATES: Comments on this notice must be received by March 24, 2017. ADDRESSES: Written comments should be submitted to: AHRQ’s OMB Desk Officer by fax at (202) 395–6974 (attention: AHRQ’s desk officer) or by email at OIRA_submission@ omb.eop.gov (attention: AHRQ’s desk officer). SUMMARY: FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: Proposed Project Pharmacy Survey on Patient Safety Culture Comparative Database In 1999, the Institute of Medicine called for health care organizations to develop a ‘‘culture of safety’’ such that their workforce and processes focus on improving the reliability and safety of E:\FR\FM\22FEN1.SGM 22FEN1 sradovich on DSK3GMQ082PROD with NOTICES 11360 Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices care for patients (IOM, 1999; To Err is Human: Building a Safer Health System). To respond to the need for tools to assess patient safety culture in health care, AHRQ developed and pilot tested the Pharmacy Survey on Patient Safety Culture with OMB approval (OMB NO. 0935–0183; Approved 08/12/ 2011). The survey is designed to enable pharmacies to assess staff opinions about patient and medication safety and quality-assurance issues, and includes 36 items that measure 11 dimensions of patient safety culture. AHRQ made the survey publicly available along with a Survey User’s Guide and other toolkit materials in October 2012 on the AHRQ Web site. The AHRQ Pharmacy Survey on Patient Safety Culture (Pharmacy SOPS) Comparative Database consists of data from the AHRQ Pharmacy SOPS Pharmacies in the U.S. are asked to voluntarily submit data from the survey to AHRQ, through its contractor, Westat. The Pharmacy SOPS Database is modeled after three other SOPS databases: Hospital SOPS [OMB NO. 0935–0162; Approved 05/04/2010]; Medical Office SOPS [OMB NO. 0935– 0196; Approved 06/12/12]; and Nursing Home SOPS [OMB NO. 0935–0195; Approved 06/12/12] that were originally developed by AHRQ in response to requests from hospitals, medical offices, and nursing homes interested in knowing how their patient safety culture survey results compare to those of other similar health care organizations. Rationale for the information collection. The Pharmacy SOPS survey and the Pharmacy SOPS Comparative Database will support AHRQ’s goals of promoting improvements in the quality and safety of health care in pharmacy settings. The survey, toolkit materials, and comparative database results are all made publicly available on AHRQ’s Web site. Technical assistance is provided by AHRQ through its contractor at no charge to pharmacies, to facilitate the use of these materials for pharmacy patient safety and quality improvement. Request for information collection approval: AHRQ requests that the OMB reapprove, under the Paperwork Reduction Act of 1995, AHRQ’s collection of information for the AHRQ Pharmacy SOPS Comparative Database; OMB NO. 0935–0218, last approved on June 12, 2014. This database will: (1) Allow pharmacies to compare their patient safety culture survey results with those of other pharmacies, (2) Provide data to pharmacies to facilitate internal assessment and VerDate Sep<11>2014 16:05 Feb 21, 2017 Jkt 241001 learning in the patient safety improvement process, and (3) Provide supplemental information to help pharmacies identify their strengths and areas with potential for improvement in patient safety culture. This study is being conducted by AHRQ through its contractor, Westat, pursuant to AHRQ’s statutory authority to conduct and support research on health care and on systems for the delivery of such care, including activities with respect to the quality, effectiveness, efficiency, appropriateness and value of health care services; quality measure and development, and database development. 42 U.S.C. 299a(a)(1), (2), and 8. Method of Collection To achieve the goal of this project the following activities and data collections will be implemented: (1) Pharmacy Eligibility and Registration Form—The point of contact (POC), often the pharmacy manager of a participating organization, completes a number of data submission steps and forms, beginning with completion of an online Eligibility and Registration Form. The purpose of this form is to collect basic demographic information about the pharmacy and initiate the registration process. (2) Data Use Agreement—The purpose of the data use agreement, completed by the pharmacy POC, is to state how data submitted by pharmacies will be used and provides confidentiality assurances. (3) Pharmacy Site Information Form— The purpose of this form, completed by the pharmacy POC, is to collect background characteristics of the pharmacy. This information will be used to analyze data collected with the Pharmacy SOPS survey. (4) Data Files Submission—POCs upload their data file(s), using the community pharmacy or hospital pharmacy data file specifications, to ensure that users submit standardized and consistent data in the way variables are named, coded, and formatted. The number of submissions to the database is likely to vary each year because pharmacies do not administer the survey and submit data every year. Data submission is typically handled by one POC who is either a pharmacy manager or a survey vendor who contracts with a pharmacy to collect and submit its data. POCs submit data on behalf of 3 pharmacies, on average, because many pharmacies are part of a multi-pharmacy system, or the POC is a vendor that is submitting data for multiple pharmacies. PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 Survey data from the AHRQ Pharmacy SOPS are used to produce three types of products: (1) A Pharmacy SOPS Comparative Database Report that is made publicly available on the AHRQ Web site (see http://www.ahrq.gov/ professionals/quality-patient-safety/ patientsafetyculture/pharmacy/pharmreports.html), (2) Individual Pharmacy Survey Feedback Reports that are confidential, customized reports produced for each pharmacy that submits data to the database (the number of reports produced is based on the number of pharmacies submitting each year); and (3) Research data sets of individual-level and pharmacy-level deidentified data to enable researchers to conduct analyses. Pharmacies are asked to voluntarily submit their Pharmacy SOPS survey data to the comparative database. The data are then cleaned and aggregated and used to produce a Comparative Database Report that displays averages, standard deviations, and percentile scores on the survey’s 36 items and 11 patient safety culture dimensions, as well as displaying these results by pharmacy characteristics (pharmacy type, number of locations, average number of prescriptions dispensed per week, etc.) and respondent characteristics (staff position, tenure, and hours worked per week). Data submitted by pharmacies are also used to give each pharmacy its own customized survey feedback report that presents the pharmacy’s results compared to the latest comparative database results. If a pharmacy submits data more than once, its survey feedback report also presents trend data, comparing its previous and most recent data. Estimated Annual Respondent Burden Exhibit 1 shows the estimated annualized burden hours for the respondents’ time to participate in the database. An estimated 100 POCs from community pharmacies and 50 POCs from hospital pharmacies, each representing an average of 3 individual pharmacies, will complete the database submission steps and forms. Completing the eligibility and registration form will take about 5 minutes. The Pharmacy Site Information Form is completed by all POCs for each of their pharmacies (150 × 3 = 450 forms in total) and is estimated to take 5 minutes to complete. Each POC will complete a data use agreement which takes 3 minutes to complete and submitting the data will take an hour on average. The total burden is estimated to be 209 hours. Exhibit 2 shows the estimated annualized cost burden based on the E:\FR\FM\22FEN1.SGM 22FEN1 11361 Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices respondents’ time to submit their data. The cost burden is estimated to be $11,222 annually. EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents/ POCs Form name Number of responses per POC Hours per response Total burden hours Eligibility and Registration Form ...................................................................... Data Use Agreement ....................................................................................... Pharmacy Site Information Form ..................................................................... Data Files Submission ..................................................................................... 150 150 150 150 1 1 3 1 5/60 3/60 5/60 1 13 8 38 150 Total .......................................................................................................... NA NA NA 209 EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of respondents/ POCs Form name Total burden hours Average hourly wage rate * Total cost burden Eligibility and Registration Form ...................................................................... Data Use Agreement ....................................................................................... Pharmacy Site Information Form ..................................................................... Data Files Submission ..................................................................................... 150 150 150 150 13 8 38 150 $53.69 53.69 53.69 53.69 $698 430 2,040 8,054 Total .......................................................................................................... NA 209 NA 11,222 * Based on the weighted average hourly wage in community pharmacies for 100 General and Operations Managers (11–1021; $49.26) and 50 General and Operations Managers (11–1021; $62.56) obtained from the May 2015 National Industry-Specific Occupational Employment and Wage Estimates: NAICS 446110—Pharmacies and Drug Stores (located at http://www.bls.gov/oes/current/naics5_446110.htm) and NAICS 622000—Hospitals (located at http://www.bls.gov/oes/current/naics3_622000.htm). sradovich on DSK3GMQ082PROD with NOTICES Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501–3521, AHRQ invites the public to comment on this proposed information collection. This is a second review opportunity. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All VerDate Sep<11>2014 16:05 Feb 21, 2017 Jkt 241001 comments will become a matter of public record. Sharon B. Arnold, Acting Director. [FR Doc. 2017–03463 Filed 2–21–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Request for Public Comment; 60 Day Proposed Information Collection: Mashpee Wampanoag Indian Health Service Unit Community Health Assessment AGENCY: Indian Health Service, HHS. Notice and request for comments. ACTION: In compliance with the Paperwork Reduction Act of 1995, the Indian Health Service (IHS) invites the general public to take this opportunity to comment on the new information collection Office of Management and Budget (OMB) Control Number 0917– NEW, titled, ‘‘Mashpee Wampanoag Community Health Assessment.’’ The purpose of this notice is to allow 60 days for public comment to be submitted directly to OMB. A copy of the draft supporting statement is SUMMARY: PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 available at www.regulations.gov (see Docket ID [IHS–2017–0001]). DATES: April 24, 2017. Your comments regarding this information collection are best assured of having full effect if received within 60 days of the date of this publication. ADDRESSES: Send your written comments, requests for more information on the collection, or requests to obtain a copy of the data collection instrument and instructions to Rita Gonsalves by one of the following methods: • Mail: Ms. Rita Gonsalves, CEO, Mashpee Wampanoag Health Service Unit, Indian Health Service, 483B Great Neck Rd. South, Mashpee, MA 02346. • Phone: 508–477–6913. • Email: Rita.Gonsalves@ihs.gov. • Fax: 508–477–0156. SUPPLEMENTARY INFORMATION: The Indian Health Service Mashpee Wampanoag Service Unit is submitting the proposed information collection to OMB for review, as required by section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995. This notice is soliciting comments from members of the public and affected agencies as required by 44 U.S.C. 3506(c)(2)(A) concerning the proposed collection of information to: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have E:\FR\FM\22FEN1.SGM 22FEN1

Agencies

[Federal Register Volume 82, Number 34 (Wednesday, February 22, 2017)]
[Notices]
[Pages 11359-11361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03463]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the intention of the Agency for 
Healthcare Research and Quality (AHRQ) to request that the Office of 
Management and Budget (OMB) to review again proposed information 
collection project: Pharmacy Survey on Patient Safety Culture 
Comparative Database.'' This proposed information collection was 
previously published in the Federal Register on November 18, 2016 and 
allowed 60 days for public comment. AHRQ did not receive any 
substantive comments. The purpose of this notice is to allow an 
additional 30 days for public comment.

DATES: Comments on this notice must be received by March 24, 2017.

ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk 
Officer by fax at (202) 395-6974 (attention: AHRQ's desk officer) or by 
email at OIRA_submission@omb.eop.gov (attention: AHRQ's desk officer).

FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports 
Clearance Officer, (301) 427-1477, or by email at 
doris.lefkowitz@AHRQ.hhs.gov.

SUPPLEMENTARY INFORMATION: 

Proposed Project

Pharmacy Survey on Patient Safety Culture Comparative Database

    In 1999, the Institute of Medicine called for health care 
organizations to develop a ``culture of safety'' such that their 
workforce and processes focus on improving the reliability and safety 
of

[[Page 11360]]

care for patients (IOM, 1999; To Err is Human: Building a Safer Health 
System). To respond to the need for tools to assess patient safety 
culture in health care, AHRQ developed and pilot tested the Pharmacy 
Survey on Patient Safety Culture with OMB approval (OMB NO. 0935-0183; 
Approved 08/12/2011). The survey is designed to enable pharmacies to 
assess staff opinions about patient and medication safety and quality-
assurance issues, and includes 36 items that measure 11 dimensions of 
patient safety culture. AHRQ made the survey publicly available along 
with a Survey User's Guide and other toolkit materials in October 2012 
on the AHRQ Web site.
    The AHRQ Pharmacy Survey on Patient Safety Culture (Pharmacy SOPS) 
Comparative Database consists of data from the AHRQ Pharmacy SOPS 
Pharmacies in the U.S. are asked to voluntarily submit data from the 
survey to AHRQ, through its contractor, Westat. The Pharmacy SOPS 
Database is modeled after three other SOPS databases: Hospital SOPS 
[OMB NO. 0935-0162; Approved 05/04/2010]; Medical Office SOPS [OMB NO. 
0935-0196; Approved 06/12/12]; and Nursing Home SOPS [OMB NO. 0935-
0195; Approved 06/12/12] that were originally developed by AHRQ in 
response to requests from hospitals, medical offices, and nursing homes 
interested in knowing how their patient safety culture survey results 
compare to those of other similar health care organizations.
    Rationale for the information collection. The Pharmacy SOPS survey 
and the Pharmacy SOPS Comparative Database will support AHRQ's goals of 
promoting improvements in the quality and safety of health care in 
pharmacy settings. The survey, toolkit materials, and comparative 
database results are all made publicly available on AHRQ's Web site. 
Technical assistance is provided by AHRQ through its contractor at no 
charge to pharmacies, to facilitate the use of these materials for 
pharmacy patient safety and quality improvement.
    Request for information collection approval: AHRQ requests that the 
OMB reapprove, under the Paperwork Reduction Act of 1995, AHRQ's 
collection of information for the AHRQ Pharmacy SOPS Comparative 
Database; OMB NO. 0935-0218, last approved on June 12, 2014.
    This database will:
    (1) Allow pharmacies to compare their patient safety culture survey 
results with those of other pharmacies,
    (2) Provide data to pharmacies to facilitate internal assessment 
and learning in the patient safety improvement process, and
    (3) Provide supplemental information to help pharmacies identify 
their strengths and areas with potential for improvement in patient 
safety culture.
    This study is being conducted by AHRQ through its contractor, 
Westat, pursuant to AHRQ's statutory authority to conduct and support 
research on health care and on systems for the delivery of such care, 
including activities with respect to the quality, effectiveness, 
efficiency, appropriateness and value of health care services; quality 
measure and development, and database development. 42 U.S.C. 
299a(a)(1), (2), and 8.

Method of Collection

    To achieve the goal of this project the following activities and 
data collections will be implemented:
    (1) Pharmacy Eligibility and Registration Form--The point of 
contact (POC), often the pharmacy manager of a participating 
organization, completes a number of data submission steps and forms, 
beginning with completion of an online Eligibility and Registration 
Form. The purpose of this form is to collect basic demographic 
information about the pharmacy and initiate the registration process.
    (2) Data Use Agreement--The purpose of the data use agreement, 
completed by the pharmacy POC, is to state how data submitted by 
pharmacies will be used and provides confidentiality assurances.
    (3) Pharmacy Site Information Form--The purpose of this form, 
completed by the pharmacy POC, is to collect background characteristics 
of the pharmacy. This information will be used to analyze data 
collected with the Pharmacy SOPS survey.
    (4) Data Files Submission--POCs upload their data file(s), using 
the community pharmacy or hospital pharmacy data file specifications, 
to ensure that users submit standardized and consistent data in the way 
variables are named, coded, and formatted.
    The number of submissions to the database is likely to vary each 
year because pharmacies do not administer the survey and submit data 
every year. Data submission is typically handled by one POC who is 
either a pharmacy manager or a survey vendor who contracts with a 
pharmacy to collect and submit its data. POCs submit data on behalf of 
3 pharmacies, on average, because many pharmacies are part of a multi-
pharmacy system, or the POC is a vendor that is submitting data for 
multiple pharmacies.
    Survey data from the AHRQ Pharmacy SOPS are used to produce three 
types of products: (1) A Pharmacy SOPS Comparative Database Report that 
is made publicly available on the AHRQ Web site (see http://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/pharmacy/pharm-reports.html), (2) Individual Pharmacy Survey Feedback 
Reports that are confidential, customized reports produced for each 
pharmacy that submits data to the database (the number of reports 
produced is based on the number of pharmacies submitting each year); 
and (3) Research data sets of individual-level and pharmacy-level de-
identified data to enable researchers to conduct analyses.
    Pharmacies are asked to voluntarily submit their Pharmacy SOPS 
survey data to the comparative database. The data are then cleaned and 
aggregated and used to produce a Comparative Database Report that 
displays averages, standard deviations, and percentile scores on the 
survey's 36 items and 11 patient safety culture dimensions, as well as 
displaying these results by pharmacy characteristics (pharmacy type, 
number of locations, average number of prescriptions dispensed per 
week, etc.) and respondent characteristics (staff position, tenure, and 
hours worked per week).
    Data submitted by pharmacies are also used to give each pharmacy 
its own customized survey feedback report that presents the pharmacy's 
results compared to the latest comparative database results. If a 
pharmacy submits data more than once, its survey feedback report also 
presents trend data, comparing its previous and most recent data.

Estimated Annual Respondent Burden

    Exhibit 1 shows the estimated annualized burden hours for the 
respondents' time to participate in the database. An estimated 100 POCs 
from community pharmacies and 50 POCs from hospital pharmacies, each 
representing an average of 3 individual pharmacies, will complete the 
database submission steps and forms. Completing the eligibility and 
registration form will take about 5 minutes. The Pharmacy Site 
Information Form is completed by all POCs for each of their pharmacies 
(150 x 3 = 450 forms in total) and is estimated to take 5 minutes to 
complete. Each POC will complete a data use agreement which takes 3 
minutes to complete and submitting the data will take an hour on 
average. The total burden is estimated to be 209 hours.
    Exhibit 2 shows the estimated annualized cost burden based on the

[[Page 11361]]

respondents' time to submit their data. The cost burden is estimated to 
be $11,222 annually.

                                  Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                     Number of       Number of
                    Form name                      respondents/    responses per     Hours per     Total burden
                                                       POCs             POC          response          hours
----------------------------------------------------------------------------------------------------------------
Eligibility and Registration Form...............             150               1            5/60              13
Data Use Agreement..............................             150               1            3/60               8
Pharmacy Site Information Form..................             150               3            5/60              38
Data Files Submission...........................             150               1               1             150
                                                 ---------------------------------------------------------------
    Total.......................................              NA              NA              NA             209
----------------------------------------------------------------------------------------------------------------


                                   Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
                                                     Number of
                    Form name                      respondents/    Total burden   Average hourly    Total cost
                                                       POCs            hours        wage rate *       burden
----------------------------------------------------------------------------------------------------------------
Eligibility and Registration Form...............             150              13          $53.69            $698
Data Use Agreement..............................             150               8           53.69             430
Pharmacy Site Information Form..................             150              38           53.69           2,040
Data Files Submission...........................             150             150           53.69           8,054
                                                 ---------------------------------------------------------------
    Total.......................................              NA             209              NA          11,222
----------------------------------------------------------------------------------------------------------------
* Based on the weighted average hourly wage in community pharmacies for 100 General and Operations Managers (11-
  1021; $49.26) and 50 General and Operations Managers (11-1021; $62.56) obtained from the May 2015 National
  Industry-Specific Occupational Employment and Wage Estimates: NAICS 446110--Pharmacies and Drug Stores
  (located at http://www.bls.gov/oes/current/naics5_446110.htm) and NAICS 622000--Hospitals (located at http://www.bls.gov/oes/current/naics3_622000.htm).

Request for Comments

    In accordance with the Paperwork Reduction Act, comments on AHRQ's 
information collection are requested with regard to any of the 
following: (a) Whether the proposed collection of information is 
necessary for the proper performance of AHRQ health care research and 
health care information dissemination functions, including whether the 
information will have practical utility; (b) the accuracy of AHRQ's 
estimate of burden (including hours and costs) of the proposed 
collection(s) of information; (c) ways to enhance the quality, utility, 
and clarity of the information to be collected; and (d) ways to 
minimize the burden of the collection of information upon the 
respondents, including the use of automated collection techniques or 
other forms of information technology.
    In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501-
3521, AHRQ invites the public to comment on this proposed information 
collection. This is a second review opportunity.
    Comments submitted in response to this notice will be summarized 
and included in the Agency's subsequent request for OMB approval of the 
proposed information collection. All comments will become a matter of 
public record.

Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-03463 Filed 2-21-17; 8:45 am]
 BILLING CODE 4160-90-P